ANKLESHWAR, GUJARAT — RPG Life Sciences has announced the formal commissioning of its expanded manufacturing blocks at its Ankleshwar plant, reinforcing its position as a trusted global pharmaceutical supplier.

The upgraded infrastructure introduces high-potency containment systems, automated blister packaging lines, and computerized SCADA monitoring systems compliant with US FDA 21 CFR Part 11 requirements.

World-Class Manufacturing Standards

The plant expansion directly responds to rising order books for immunosuppressive tablets and gastrointestinal formulations across export markets in the UK, Germany, Canada, and Australia.

"Quality and compliance are non-negotiable foundations of RPG Life Sciences. The modernization of Ankleshwar reflects our ongoing commitment to environmentally sustainable, defect-free production that meets the highest global regulatory benchmarks."